Blueberries Medical Corp. (FRA:1OA)
Germany · Delayed Price · Currency is EUR 0.0060
0.00 (0.00%)
At close: Nov 28, 2025
Blueberries Medical Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| 0.41 | 0.47 | 0.29 | 0.24 | 0.14 | 0.07 | Upgrade | |
Revenue Growth (YoY) | 55.74% | 63.53% | 22.43% | 69.70% | 110.29% | - | Upgrade |
Cost of Revenue | 0.26 | 0.31 | 0.2 | 0.25 | 0.38 | 0 | Upgrade |
Gross Profit | 0.15 | 0.16 | 0.08 | -0.02 | -0.25 | 0.06 | Upgrade |
Selling, General & Admin | 1.37 | 0.94 | 1.29 | 1.36 | 0.67 | 2.55 | Upgrade |
Operating Expenses | 1.5 | 1.08 | 1.46 | 1.62 | 1.54 | 4.19 | Upgrade |
Operating Income | -1.35 | -0.91 | -1.38 | -1.64 | -1.79 | -4.12 | Upgrade |
Interest Expense | -0 | - | -0.26 | -0.36 | -0.27 | -0.12 | Upgrade |
Currency Exchange Gain (Loss) | -0.03 | -0.07 | 0.15 | -0.12 | -0.17 | -0.04 | Upgrade |
Other Non Operating Income (Expenses) | -0.01 | 0 | 0.02 | 0.51 | 0.38 | -0.65 | Upgrade |
EBT Excluding Unusual Items | -1.39 | -0.98 | -1.47 | -1.61 | -1.84 | -4.94 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | -0.57 | - | Upgrade |
Gain (Loss) on Sale of Assets | -0.17 | -0.17 | 0.02 | 0.02 | - | - | Upgrade |
Asset Writedown | - | - | -0.18 | - | -2.82 | - | Upgrade |
Other Unusual Items | - | - | - | 0.13 | 0.09 | - | Upgrade |
Pretax Income | -1.55 | -1.15 | -1.64 | -1.47 | -5.15 | -4.94 | Upgrade |
Net Income | -1.55 | -1.15 | -1.64 | -1.47 | -5.15 | -4.94 | Upgrade |
Net Income to Common | -1.55 | -1.15 | -1.64 | -1.47 | -5.15 | -4.94 | Upgrade |
Shares Outstanding (Basic) | 438 | 399 | 219 | 169 | 149 | 124 | Upgrade |
Shares Outstanding (Diluted) | 438 | 399 | 219 | 169 | 149 | 124 | Upgrade |
Shares Change (YoY) | 23.34% | 81.95% | 29.85% | 13.73% | 19.83% | 13.78% | Upgrade |
EPS (Basic) | -0.00 | -0.00 | -0.01 | -0.01 | -0.03 | -0.04 | Upgrade |
EPS (Diluted) | -0.00 | -0.00 | -0.01 | -0.01 | -0.03 | -0.04 | Upgrade |
Free Cash Flow | -1.31 | -0.8 | -1.35 | -1.47 | -1.69 | -3.22 | Upgrade |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.03 | Upgrade |
Gross Margin | 36.90% | 34.90% | 29.22% | -7.53% | -176.91% | 94.58% | Upgrade |
Operating Margin | -325.05% | -193.70% | -477.44% | -696.79% | -1289.55% | -6251.53% | Upgrade |
Profit Margin | -375.36% | -243.64% | -567.30% | -623.44% | -3709.64% | -7487.51% | Upgrade |
Free Cash Flow Margin | -315.93% | -169.03% | -470.00% | -623.72% | -1217.90% | -4883.95% | Upgrade |
EBITDA | -1.24 | -0.81 | -1.23 | -1.35 | -1.08 | -3.57 | Upgrade |
EBITDA Margin | - | -171.38% | - | - | - | - | Upgrade |
D&A For EBITDA | 0.1 | 0.11 | 0.15 | 0.29 | 0.7 | 0.55 | Upgrade |
EBIT | -1.35 | -0.91 | -1.38 | -1.64 | -1.79 | -4.12 | Upgrade |
EBIT Margin | - | -193.70% | - | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.